Mark de Souza

Mark de Souza is an accomplished business leader with extensive experience in the biotech and pharmaceutical industries. Currently serving as President and CEO of SonALAsense, Mark also holds positions as Co-Founder and Board Member of Phoenicis Therapeutics, and Co-Founder and Executive Chairman of Flightpath Biosciences, Inc. Previous roles include Co-Founder and President of Willow Neuroscience and Co-Founder and Board Member of NFlection Therapeutics, Inc. Mark has also been instrumental in the founding and leadership of several other companies, including Chromaderm Inc, FIBRX Derm, Inc., and SeylanMED, LLC, while serving as Executive Chairman at PellePharm. Additionally, Mark provided consulting services at Shire.